Cytek Biosciences (CTKB) Capital Expenditures Growth (1y) (2021 - 2026)
Cytek Biosciences (CTKB) Capital Expenditures Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -1.00% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 10.38% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 24.20% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 35.70% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -9.99% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 16.28% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -4.32% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -6.52% |
| 10 | Cytek Biosciences | 620.12 Mn | 546.27 Mn | 28.34 Mn | 40.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 40.52% |
| Mar 31, 2026 | 826.50% |
| Dec 31, 2025 | -3,887.18% |
| Sep 30, 2025 | 300.07% |
| Jun 30, 2025 | -118.42% |
| Mar 31, 2025 | -58.73% |
| Dec 31, 2024 | 102.51% |
| Sep 30, 2024 | -148.78% |
| Jun 30, 2024 | 1,066.06% |
| Mar 31, 2024 | 307.91% |
| Dec 31, 2023 | -147.60% |
| Sep 30, 2023 | 180.90% |
| Jun 30, 2023 | -105.80% |
| Mar 31, 2023 | -39.04% |
| Dec 31, 2022 | 403.86% |
| Sep 30, 2022 | -59.34% |
| Jun 30, 2022 | 1,199.42% |
| Mar 31, 2022 | -55.21% |
| Dec 31, 2021 | 196.43% |
| Sep 30, 2021 | 475.95% |